Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Alliance Boots Buys $91 Million Stake in Chinese Drug Wholesaler

Sept. 16 (Bloomberg) -- Alliance Boots GmbH, the largest U.K. drugstore chain, will buy a 12 percent stake in China’s Nanjing Pharmaceutical Company Ltd. for about 56 million pounds ($91 million), it said in a statement today.

Alliance Boots will become the second-largest shareholder as part of a strategic alliance between the two companies. Nanjing Pharmaceutical Company is the fifth-biggest drugs wholesaler in China with sales of 2 billion pounds last year, Boots said in the announcement.

The deal will allow the Nanjing, China-based company to “improve its management practices, achieve greater performance, and help China’s medical industry reach global standards,” said its chairman, Zhou Yaoping.

Walgreen Co., the biggest U.S. drugstore operator, said in June it agreed to buy 45 percent of Alliance Boots from owners including private-equity firm KKR & Co. and Alliance Boots Chairman Stefano Pessina.

To contact the reporter on this story: Kit Chellel in London at cchellel@bloomberg.net

To contact the editor responsible for this story: Dick Schumacher at dschumacher@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.